Clinical trial / 2015
Very little titanium dioxide is absorbed gastrointestinally in humans after oral challenge, with no difference across three particle sizes.
Researchers conducted human in vivo and in vitro studies to evaluate the gastrointestinal absorption of titanium dioxide nanoparticles compared with larger particles. Human volunteer studies showed that very little titanium dioxide is absorbed gastrointestinally following an oral challenge, with no demonstrable difference in absorption across the three particle sizes tested. In vitro tests showed that all formulations agglomerated in simulated gastric fluid and when dispersed in polymeric or elemental foods, with virtually no translocation across the cell layer. The study found no evidence that nanoparticulate titanium dioxide is more likely to be absorbed in the gut than micron-sized particles.
- Study type
- In vivo human volunteer challenge and in vitro study
- Who was studied
- Human volunteers (sample size not stated)
- What was measured
- Gastrointestinal absorption and translocation of titanium dioxide particles
THE PAPER
Human in vivo and in vitro studies on gastrointestinal absorption of titanium dioxide nanoparticles.
Jones K, Morton J, Smith I, Jurkschat K, Harding AH, Evans G. Toxicol Lett, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.